Avestria Ventures is a venture capital firm that invests in early-stage women's health companies and female-led life science ventures. Their strategy focuses on these under-invested sectors, seeking companies that utilize technology and/or data to improve healthcare quality, access, or reduce costs.
100% of their portfolio is in Healthcare. Average disclosed round size is $29.0M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$141.4M
Top Stage
Series C
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Midi Health | Series B | $60M | Apr 2024 |
 Avation Medical | Series C | $22M | Feb 2024 |
 Raydiant Oximetry, Inc. | Series A | $5M | Nov 2021 |
Top Co-Investors
ShangBay Capital1 shared
Asahi Kasei1 shared
Angelini Ventures1 shared
JobsOhio1 shared
Felicis Ventures1 shared
Emerson Collective1 shared
GV (Google Ventures)1 shared
Memorial Hermann1 shared
Semper Virens1 shared
Icon Ventures1 shared
GingerBread Capital1 shared
Able Partners1 shared
G9 Ventures1 shared
Operator Collective1 shared
f7 Ventures1 shared
Muse Capital1 shared
1843 Capital1 shared
K50 Ventures1 shared
Band of Angels1 shared
SteelSky Ventures1 shared
Last updated: 16 April 2026